Sort
82,697 grants matching “vaccine development”
HBV Capsid Effectors
$702,799Raymond F. Schinazi · Emory University · R01 · FY2025 · AI
HBV Capsid Effectors
$702,799Raymond F. Schinazi · Emory University · R01 · FY2023 · AI
CORALE-SeroNet Project 2
$702,781Noah M Merin · Cedars-Sinai Medical Center · U54 · FY2020 · CA
Resource for Nonhuman Primate Cell Depleting Antibodies
$702,756Keith A Reimann · Beth Israel Deaconess Medical Center · R24 · FY2010 · RR
Probing the germlines of broadly neutralizing anti-HIV antibodies in knockin mice
$702,711Dennis R. Burton · Scripps Research Institute, The · U01 · FY2012 · AI
The longer-term impact of prenatal exposure to SARS-CoV-2 infection and the COVID-19 vaccine on behavior, cognition, and brain functioning in the child
$702,685Anna-Sophie Rommel · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · HD
Biomarker Approach to Screening for the early detection of HPV-related Oropharyngeal Cancer (BASH OPC)
$702,649Anna R Giuliano · H. Lee Moffitt Cancer Ctr & Res Inst · U01 · FY2024 · DE
Modeling Mechanisms of Adjuvanted Influenza Vaccine Induced IgG Repertoire Diversity and Heterosubtypic Immunity
$702,619Martin S Zand · University Of Rochester · R01 · FY2018 · AI
Investigation of Oral HPV Infection Natural History and Biomarkers of Persistent Infection: The HIM Study
$702,568Anna R Giuliano · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2017 · CA
Optimization of Small-Molecule Inhibitors of Shiga and Ricin Toxins
$702,538Yuan-Ping Pang · Mayo Clinic Rochester · U01 · FY2011 · AI
Capsular serotype in group B Streptococcus colonization and disease
$702,525Adam Jonathan Ratner · New York University School Of Medicine · R01 · FY2022 · AI
Capsular serotype in group B Streptococcus colonization and disease
$702,525Adam Jonathan Ratner · New York University School Of Medicine · R01 · FY2023 · AI
NYC Transit Workers and COVID-19: Impact of Multilevel Interventions
$702,414Robyn R.m. Gershon · New York University · R01 · FY2022 · NR
Evaluation of Memory Responses and Biomarkers from a Phase IEnterotoxigenic Escherichia coli (ETEC) Intramuscular SubunitVaccine with dmLT Adjuvant
$702,414Elizabeth B Norton · Tulane University Of Louisiana · R01 · FY2024 · AI
Evaluating Modes of Influenza Transmission using a Randomized Controlled Trial (EMIT-2-RCT)
$702,413Donald K Milton · Univ Of Maryland, College Park · U19 · FY2025 · AI
Development of an Oral Pan-Coronavirus Drug Cocktail
$702,361Stephen J. Polyak · University Of Washington · R01 · FY2023 · AI
Dime la VerDAD (Verify, Debunk, and Disseminate)
$702,357Marina Del Rios · University Of Iowa · R01 · FY2023 · MD
EpiMoRPH: A simulation environment for generating spatially-refined intervention strategies for the control of infectious disease
$702,342Joseph Mihaljevic · Northern Arizona University · R01 · FY2025 · AI
CCR Genomics Core
$702,309Elizabeth Conner · Division Of Basic Sciences - Nci · ZIC · FY2015 · CA
Platelets in radiation-induced immune dysregulation
$702,309Rupak Pathak · Univ Of Arkansas For Med Scis · U01 · FY2024 · AI
Development of a High-Throughput Microfludics-Enabled Functional Assay for Rapidly Identifying Neutralizing Antibodies
$702,284Paul De Figueiredo · Texas A&M University · R01 · FY2019 · AI
Synergistic effects of HIV and age on naive CD4+ T-cell senescence
$702,269Beth D. Jamieson-Karavodin · University Of California Los Angeles · R01 · FY2009 · AG
Western States Node of the National Drug Abuse Treatment Clinical Trials Network
$702,234James L. Sorensen · University Of California, San Francisco · UG1 · FY2017 · DA
Trusted Messengers: Supporting Physicians in Promoting COVID-19 Vaccination
$702,150Kimberly Fisher · Univ Of Massachusetts Med Sch Worcester · R01 · FY2023 · MD
Interaction of HIV envelope with cell surface receptors
$702,068Anthony S. Fauci · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI